{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:19:56Z","timestamp":1776097196030,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]},{"name":"Spanish Institute of Health ISCIII","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-024-02399-5","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T15:15:08Z","timestamp":1724426108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epicardial and liver fat implications in albuminuria: a retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Carolina M.","family":"Perdomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Martin-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ezponda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorka","family":"Bastarrika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Garcia-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 I.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Colina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Escalada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Fr\u00fchbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"2399_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms23137007","volume":"23","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A. MAFLD and CKD: an updated narrative review. Int J Mol Sci. 2022;23:1\u201311.","journal-title":"Int J Mol Sci"},{"issue":"5S","key":"2399_CR2","first-page":"S1","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1\u2013127.","journal-title":"Kidney Int"},{"issue":"10302","key":"2399_CR3","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398(10302):786\u2013802.","journal-title":"Lancet"},{"key":"2399_CR4","first-page":"1","volume":"81","author":"V Lezaic","year":"2015","unstructured":"Lezaic V. Albuminuria as a biomarker of the renal disease. Biomarkers Kidney Dis. 2015;81:1\u201318.","journal-title":"Biomarkers Kidney Dis."},{"key":"2399_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3:514\u201325.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2399_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010546","volume":"8","author":"Y Mok","year":"2019","unstructured":"Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, et al. Albuminuria as a predictor of cardiovascular outcomes in patients with acute myocardial infarction. J Am Heart Assoc. 2019;8(8): e010546.","journal-title":"J Am Heart Assoc"},{"key":"2399_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"2399_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"2399_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.04.031","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO); European Association for the Study of the Liver (EASL)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO); European Association for the Study of the Liver (EASL). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031. (Epub ahead of print)","journal-title":"J Hepatol"},{"issue":"5","key":"2399_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11154-023-09797-2","volume":"24","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Avil\u00e9s-Olmos I, Dicker D, Fr\u00fchbeck G. Towards an adiposity-related disease framework for the diagnosis and management of obesities. Rev Endocr Metab Disord. 2023;24(5):795\u2013807.","journal-title":"Rev Endocr Metab Disord"},{"key":"2399_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom12010105","volume":"12","author":"S Ciardullo","year":"2022","unstructured":"Ciardullo S, Ballabeni C, Trevisan R, Perseghin G. Liver stiffness, albuminuria and chronic kidney disease in patients with NAFLD: a systematic review and meta-analysis. Biomolecules. 2022;12:1\u201310.","journal-title":"Biomolecules"},{"issue":"7","key":"2399_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","volume":"79","author":"E Muzurovi\u0107","year":"2022","unstructured":"Muzurovi\u0107 E, Peng CC, Belanger MJ, Sanoudou D, Mikhailidis DP, Mantzoros CS. Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors. Hypertension. 2022;79(7):1319\u201326.","journal-title":"Hypertension"},{"issue":"3","key":"2399_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C, Targher G, et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis of observational studies. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"key":"2399_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.dld.2020.10.014","volume":"53","author":"Y Schonmann","year":"2021","unstructured":"Schonmann Y, Yeshua H, Bentov I, Zelber-Sagi S. Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population. Dig Liver Dis. 2021;53:79\u201385.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"2399_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/MEG.0000000000001169","volume":"30","author":"K Wijarnpreecha","year":"2018","unstructured":"Wijarnpreecha K, Thongprayoon C, Boonpheng B, Panjawatanan P, Sharma K, Ungprasert P, Pungpapong S, Cheungpasitporn W. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30(9):986\u201394.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2399_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","volume":"79","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2017;79:64\u201376.","journal-title":"Metabolism"},{"issue":"1","key":"2399_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101506","volume":"50","author":"J Bilson","year":"2024","unstructured":"Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1): 101506.","journal-title":"Diabetes Metab"},{"issue":"9","key":"2399_CR18","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3390\/jcm10092040","volume":"10","author":"CM Perdomo","year":"2021","unstructured":"Perdomo CM, Garcia-Fernandez N, Escalada J. Diabetic kidney disease, cardiovascular disease and non-alcoholic fatty liver disease: a new triumvirate? J Clin Med. 2021;10(9):2040.","journal-title":"J Clin Med"},{"key":"2399_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","volume":"19","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19:593\u2013606.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"2399_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0003319715576672","volume":"67","author":"SN Psychari","year":"2016","unstructured":"Psychari SN, Rekleiti N, Papaioannou N, Varhalama E, Drakoulis C, Apostolou TS, Iliodromitis EK. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology. 2016;67(1):41\u20138.","journal-title":"Angiology"},{"key":"2399_CR21","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2015.01.012","volume":"62","author":"S Petta","year":"2015","unstructured":"Petta S, Crax\u00ec A. Epicardial fat in patients with non-alcoholic fatty liver disease. J Hepatol. 2015;62:1215.","journal-title":"J Hepatol"},{"issue":"3","key":"2399_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jacl.2016.01.008","volume":"10","author":"BJ Kim","year":"2016","unstructured":"Kim BJ, Cheong ES, Kang JG, Kim BS, Kang JH. Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: from the CAESAR study. J Clin Lipidol. 2016;10(3):619\u201326.","journal-title":"J Clin Lipidol"},{"key":"2399_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/ckj\/sfz030","volume":"13","author":"T Saritas","year":"2020","unstructured":"Saritas T, Reinartz SD, Nadal J, Schmoee J, Schmid M, Marwan M, et al. Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease. Clin Kidney J. 2020;13:571\u20139.","journal-title":"Clin Kidney J"},{"key":"2399_CR24","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118:1117\u201323.","journal-title":"Gastroenterology"},{"issue":"11","key":"2399_CR25","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.amjcard.2011.07.031","volume":"108","author":"H Shmilovich","year":"2011","unstructured":"Shmilovich H, Dey D, Cheng VY, Rajani R, Nakazato R, Otaki Y, Nakanishi R, Slomka PJ, Thomson LE, Hayes SW, Friedman JD, Gransar H, Wong ND, Shaw LJ, Budoff M, Rozanski A, Berman DS. Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol. 2011;108(11):1680\u20135.","journal-title":"Am J Cardiol"},{"key":"2399_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF00587008","volume":"325","author":"D Mitchell","year":"1971","unstructured":"Mitchell D, Strydom NB, van Graan CH, Van Der Walt WH. Human surface area: comparison of the du bois formula with direct photometric measurement. Pfl\u00fcgers Arch Eur J Physiol. 1971;325:188\u201390.","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"2399_CR27","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","volume":"55","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622\u201330.","journal-title":"Diabetologia"},{"issue":"6","key":"2399_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.nefro.2018.04.004","volume":"38","author":"M Gorostidi","year":"2018","unstructured":"Gorostidi M, S\u00e1nchez-Mart\u00ednez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamar\u00eda R, et al. Prevalencia de enfermedad renal cr\u00f3nica en Espa\u00f1a: impacto de la acumulaci\u00f3n de factores de riesgo cardiovascular. Nefrologia. 2018;38(6):606\u201315.","journal-title":"Nefrologia"},{"key":"2399_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03095-3","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A nesw framework for the diagnosis staging and management of obesity in adults. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03095-3. (Epub ahead of print).","journal-title":"Nat Med"},{"key":"2399_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Beatrice G, Csermely A, Lonardo A, Schattenberg JM, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71:156\u201362.","journal-title":"Gut"},{"issue":"7","key":"2399_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, Ekstedt M, Kechagias S, Hamaguchi M, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7): e1001680.","journal-title":"PLoS Med"},{"key":"2399_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72:785\u2013801.","journal-title":"J Hepatol"},{"key":"2399_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102780","volume":"17","author":"N Agustanti","year":"2023","unstructured":"Agustanti N, Soetedjo NNM, Damara FA, Iryaningrum MR, Permana H, Bestari MB, et al. The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: a systematic review and meta-analysis. Diabetes Metab Syndr Clin Res Rev. 2023;17: 102780.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2399_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.17219\/acem\/155017","volume":"32","author":"Y Chen","year":"2022","unstructured":"Chen Y, Bai W, Mao D, Long F, Wang N, Wang K, et al. The relationship between non-alcoholic fatty liver disease and incidence of chronic kidney disease for diabetic and non-diabetic subjects: a meta-analysis. Adv Clin Exp Med. 2022;32:407\u201314.","journal-title":"Adv Clin Exp Med."},{"key":"2399_CR35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2215\/CJN.00540107","volume":"2","author":"M Ferris","year":"2007","unstructured":"Ferris M, Hogan SL, Chin H, Shoham DA, Gipson DS, Gibson K, et al. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol. 2007;2:1207\u201314.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2399_CR36","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1097\/CM9.0000000000001513","volume":"134","author":"HJ Zhang","year":"2021","unstructured":"Zhang HJ, Wang YY, Chen C, Lu YL, Wang NJ, Guo LS. Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999\u20132016. Chin Med J (Engl). 2021;134:1593\u2013601.","journal-title":"Chin Med J (Engl)"},{"key":"2399_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.diabet.2019.11.004","volume":"46","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Turino T, Lando MG, Gjini K, Byrne CD, Zusi C, et al. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes Metab. 2020;46:296\u2013303.","journal-title":"Diabetes Metab"},{"key":"2399_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108226","volume":"36","author":"I Mikolasevic","year":"2022","unstructured":"Mikolasevic I, Domislovic V, Ruzic A, Hauser G, Rahelic D, Klobucar-Majanovic S, et al. Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. J Diabetes Complications. 2022;36: 108226.","journal-title":"J Diabetes Complications"},{"key":"2399_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/biomedicines10061245","volume":"10","author":"GE Chung","year":"2022","unstructured":"Chung GE, Han K, Lee KN, Cho EJ, Bae JH, Yang SY, et al. Combined effects of chronic kidney disease and nonalcoholic fatty liver disease on the risk of cardiovascular disease in patients with diabetes. Biomedicines. 2022;10:1245.","journal-title":"Biomedicines."},{"key":"2399_CR40","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s40618-019-1011-8","volume":"42","author":"M Reinhardt","year":"2019","unstructured":"Reinhardt M, Cushman TR, Thearle MS, Krakoff J. Epicardial adipose tissue is a predictor of decreased kidney function and coronary artery calcification in youth- and early adult onset type 2 diabetes mellitus. J Endocrinol Invest. 2019;42:979\u201386.","journal-title":"J Endocrinol Invest"},{"key":"2399_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12916-023-02891-x","volume":"21","author":"T Hydes","year":"2023","unstructured":"Hydes T, Kennedy O, Buchanan R, Cuthbertson D, Parkes J, Fraser S, et al. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective study using UK Biobank data. BMC Med. 2023;21:185.","journal-title":"BMC Med"},{"key":"2399_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/joim.12344","volume":"278","author":"AC Cordeiro","year":"2015","unstructured":"Cordeiro AC, Amparo FC, Oliveira MAC, Amodeo C, Smanio P, Pinto IMF, et al. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3\u20135 chronic kidney disease. J Intern Med. 2015;278:77\u201387.","journal-title":"J Intern Med"},{"key":"2399_CR43","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/jcm11051308","volume":"11","author":"K Turkmen","year":"2022","unstructured":"Turkmen K, Ozer H, Kusztal M. The relationship of epicardial adipose tissue and cardiovascular disease in chronic kidney disease and hemodialysis patients. J Clin Med. 2022;11:1308.","journal-title":"J Clin Med"},{"issue":"9","key":"2399_CR44","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1002\/jcp.29573","volume":"235","author":"N Katsiki","year":"2020","unstructured":"Katsiki N, Mikhailidis DP. Excessive \u201corthotopic\u201d fat accumulation: links with cardiometabolic diseases and potential drug treatment. J Cell Physiol. 2020;235(9):6321\u20132.","journal-title":"J Cell Physiol"},{"issue":"14","key":"2399_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030269","volume":"12","author":"D Miyamori","year":"2023","unstructured":"Miyamori D, Tanaka M, Sato T, Endo K, Mori K, Mikami T, et al. Coexistence of metabolic dysfunction-associated fatty liver disease and chronic kidney disease is a more potent risk factor for ischemic heart disease. J Am Heart Assoc. 2023;12(14): e030269.","journal-title":"J Am Heart Assoc"},{"key":"2399_CR46","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.3748\/wjg.v28.i39.5691","volume":"28","author":"P Theofilis","year":"2022","unstructured":"Theofilis P, Vordoni A, Kalaitzidis RG. Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: epidemiology, pathophysiologic mechanisms, and treatment considerations. World J Gastroenterol. 2022;28:5691\u2013706.","journal-title":"World J Gastroenterol"},{"key":"2399_CR47","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrgastro.2012.79","volume":"9","author":"E Bonora","year":"2012","unstructured":"Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9:372\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2399_CR48","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"TY Wang","year":"2022","unstructured":"Wang TY, Wang RF, Bu ZY, Targher G, Byrne CD, Sun DQ, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18:259\u201368.","journal-title":"Nat Rev Nephrol"},{"key":"2399_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2020.104023","volume":"131","author":"N Hamjane","year":"2020","unstructured":"Hamjane N, Benyahya F, Nourouti NG, Mechita MB, Barakat A. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review. Microvasc Res. 2020;131: 104023.","journal-title":"Microvasc Res"},{"key":"2399_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0009-9120(02)00320-X","volume":"35","author":"J G\u00f3mez-Ambrosi","year":"2002","unstructured":"G\u00f3mez-Ambrosi J, Salvador J, P\u00e1ramo JA, Orbe J, De Irala J, Diez-Caballero A, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem. 2002;35:315\u201320.","journal-title":"Clin Biochem"},{"key":"2399_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00125-003-1053-4","volume":"46","author":"G Fr\u00fchbeck","year":"2003","unstructured":"Fr\u00fchbeck G, G\u00f3mez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia. 2003;46:143\u201372.","journal-title":"Diabetologia"},{"issue":"5","key":"2399_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2174\/1570161114666160722112738","volume":"14","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Athyros VG, Mikhailidis DP. Abnormal Peri-Organ or Intra-organ Fat (APIFat) deposition: an underestimated predictor of vascular risk? Curr Vasc Pharmacol. 2016;14(5):432\u201341.","journal-title":"Curr Vasc Pharmacol"},{"key":"2399_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2022.111590","volume":"96","author":"FG Ferreira","year":"2022","unstructured":"Ferreira FG, Reitz LK, Valmorbida A, Papini Gabiatti M, Hansen F, Faria Di Pietro P, et al. Metabolically unhealthy and overweight phenotypes are associated with increased levels of inflammatory cytokines: a population-based study. Nutrition. 2022;96: 111590.","journal-title":"Nutrition"},{"issue":"3","key":"2399_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1381\/096089206776116525","volume":"16","author":"J G\u00f3mez-Ambrosi","year":"2006","unstructured":"G\u00f3mez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catal\u00e1n V, Rodr\u00edguez A, Jes\u00fas Gil M, Fr\u00fchbeck G. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg. 2006;16(3):262\u20139.","journal-title":"Obes Surg"},{"key":"2399_CR55","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2119\/molmed.2011.00144","volume":"17","author":"V Catal\u00e1n","year":"2011","unstructured":"Catal\u00e1n V, G\u00f3mez-Ambrosi J, Rodr\u00edgue A, Ram\u00edrez B, Rotellar F, Valent\u00ed V, et al. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 2011;17:1157\u201367.","journal-title":"Mol Med"},{"key":"2399_CR56","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/NEJMra2032804","volume":"386","author":"AM Cypess","year":"2022","unstructured":"Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386:768\u201379.","journal-title":"N Engl J Med"},{"key":"2399_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185:419\u201346.","journal-title":"Cell"},{"key":"2399_CR58","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","volume":"6","author":"P Stenvinkel","year":"2021","unstructured":"Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, et al. Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Reports. 2021;6:1775\u201387.","journal-title":"Kidney Int Reports"},{"key":"2399_CR59","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.3390\/ijms23105511","volume":"23","author":"M De Fano","year":"2022","unstructured":"De Fano M, Bartolini D, Tortoioli C, Vermigli C, Malara M, Galli F, et al. Adipose tissue plasticity in response to pathophysiological cues: a connecting link between obesity and its associated comorbidities. Int J Mol Sci. 2022;23:5511.","journal-title":"Int J Mol Sci"},{"key":"2399_CR60","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/ars.2012.4641","volume":"19","author":"A Nguyen Dinh Cat","year":"2013","unstructured":"Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxidants Redox Signal. 2013;19:1110\u201320.","journal-title":"Antioxidants Redox Signal"},{"key":"2399_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11030677","volume":"11","author":"CM Perdomo","year":"2019","unstructured":"Perdomo CM, Fr\u00fchbeck G, Escalada J. Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients. 2019;11:1\u201325.","journal-title":"Nutrients"},{"key":"2399_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11020454","volume":"11","author":"G Fr\u00fchbeck","year":"2019","unstructured":"Fr\u00fchbeck G, Catal\u00e1n V, Rodr\u00edguez A, Ram\u00edrez B, Becerril S, Salvador J, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019;11:1\u201313.","journal-title":"Nutrients"},{"key":"2399_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-022-02795-7","volume":"23","author":"YC Park","year":"2022","unstructured":"Park YC, Lee S, Kim YS, Park JM, Han K, Lee H, et al. Serum leptin level and incidence of CKD: a longitudinal study of adult enrolled in the Korean genome and epidemiology study(KoGES). BMC Nephrol. 2022;23:1\u20139.","journal-title":"BMC Nephrol"},{"key":"2399_CR64","first-page":"1","volume":"8","author":"L D\u2019Marco","year":"2021","unstructured":"D\u2019Marco L, Puchades MJ, Panizo N, Romero-Parra M, Gand\u00eda L, Gim\u00e9nez-Civera E, et al. Cardiorenal fat: a cardiovascular risk factor with implications in chronic kidney disease. Front Med. 2021;8:1\u20138.","journal-title":"Front Med"},{"key":"2399_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.860799","volume":"13","author":"Y Pincu","year":"2022","unstructured":"Pincu Y, Yoel U, Haim Y, Makarenkov N, Maixner N, Shaco-Levy R, et al. Assessing obesity-related adipose tissue disease (OrAD) to improve precision medicine for patients living with obesity. Front Endocrinol (Lausanne). 2022;13:1\u201317.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2399_CR66","doi-asserted-by":"publisher","first-page":"13320","DOI":"10.3390\/ijms232113320","volume":"23","author":"A Lonardo","year":"2022","unstructured":"Lonardo A, Mantovani A, Targher G, Baffy G. Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. Int J Mol Sci. 2022;23:13320.","journal-title":"Int J Mol Sci"},{"key":"2399_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.655871","volume":"8","author":"C Garc\u00eda-Carro","year":"2021","unstructured":"Garc\u00eda-Carro C, Vergara A, Bermejo S, Azancot MA, Sellar\u00e9s J, Soler MJ. A nephrologist perspective on obesity: from kidney injury to clinical management. Front Med. 2021;8: 655871.","journal-title":"Front Med"},{"key":"2399_CR68","doi-asserted-by":"publisher","first-page":"F273","DOI":"10.1152\/ajprenal.00547.2014","volume":"309","author":"X Zhang","year":"2015","unstructured":"Zhang X, Lerman LO. Obesity and renovascular disease. Am J Physiol - Ren Physiol. 2015;309:F273\u20139.","journal-title":"Am J Physiol - Ren Physiol"},{"key":"2399_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01114-6","author":"C Roderburg","year":"2023","unstructured":"Roderburg C, Krieg S, Krieg A, Demir M, Luedde T, Kostev K, et al. Non - alcoholic fatty liver disease (NAFLD )is associated with an increased incidence of chronic kidney disease (CKD). Eur J Med Res. 2023. https:\/\/doi.org\/10.1186\/s40001-023-01114-6.","journal-title":"Eur J Med Res"},{"issue":"5","key":"2399_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40618-017-0799-3","volume":"41","author":"MG Radaelli","year":"2018","unstructured":"Radaelli MG, Martucci F, Perra S, Accornero S, Castoldi G, Lattuada G, Manzoni G, Perseghin G. NAFLD\/NASH in patients with type 2 diabetes and related treatment options. J Endocrinol Invest. 2018;41(5):509\u201321.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2399_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.nefroe.2024.03.009","volume":"44","author":"S Benlloch","year":"2024","unstructured":"Benlloch S, Moncho F, G\u00f3rriz JL. Targeting metabolic-associated fatty liver disease in diabetic kidney disease: a call to action. Nefrologia (Engl Ed). 2024;44(2):129\u201338.","journal-title":"Nefrologia (Engl Ed)"},{"issue":"11","key":"2399_CR72","first-page":"975","volume":"130","author":"AC Perdomo","year":"2020","unstructured":"Perdomo AC, Ingianna PD, Escalada J, Petta S, G\u00f3mez R, Ampuero J. Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice Pol. Arch Intern Med. 2020;130(11):975\u201385.","journal-title":"Arch Intern Med"},{"issue":"7","key":"2399_CR73","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/oby.23459","volume":"30","author":"S Hu","year":"2022","unstructured":"Hu S, Li X, Sun Y, Wu S, Lan Y, Chen S, Wang Y, Liao W, Wang X, Zhang D, Yuan X, Gao J, Wang L. Short-term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease. Obesity (Silver Spring). 2022;30(7):1495\u2013506.","journal-title":"Obesity (Silver Spring)"},{"issue":"10382","key":"2399_CR74","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401(10382):1116\u201330.","journal-title":"Lancet"},{"issue":"6","key":"2399_CR75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, MAESTRO-NASH Investigators. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509.","journal-title":"N Engl J Med"},{"issue":"3","key":"2399_CR76","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1124\/pharmrev.123.001087","volume":"76","author":"M Kokkorakis","year":"2024","unstructured":"Kokkorakis M, Muzurovi\u0107 E, Vol\u010dan\u0161ek \u0160, Chakhtoura M, Hill MA, Mikhailidis DP, Mantzoros CS. Steatotic liver disease: pathophysiology and emerging pharmacotherapies. Pharmacol Rev. 2024;76(3):454\u201399.","journal-title":"Pharmacol Rev"},{"key":"2399_CR77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401943","author":"R Loomba","year":"2024","unstructured":"Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ, SYNERGY-NASH Investigators. Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis. N Engl J Med. 2024. https:\/\/doi.org\/10.1056\/NEJMoa2401943. (Epub ahead of print).","journal-title":"N Engl J Med"},{"key":"2399_CR78","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3390\/jcm12103377","volume":"12","author":"C Gerdes","year":"2023","unstructured":"Gerdes C, M\u00fcller N, Wolf G, Busch M. Nephroprotective properties of antidiabetic drugs. J Clin Med. 2023;12:3377.","journal-title":"J Clin Med"},{"issue":"5","key":"2399_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/10742484211006997","volume":"26","author":"EM Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 EM, Vujo\u0161evi\u0107 S, Mikhailidis DP. Can we decrease epicardial and pericardial fat in patients with diabetes? J Cardiovasc Pharmacol Ther. 2021;26(5):415\u201336.","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02399-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02399-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T15:37:01Z","timestamp":1724427421000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02399-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02399-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol (2019.080) was approved by the ethics committee of Cl\u00ednica Universidad de Navarra. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}